Day One Biopharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 7.87 M | $109.65 M | 0.00% | 8.15% |
| FMR LLC | 11/13/2024 | 7.41 M | $103.25 M | 178.51% | 7.67% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 11/13/2024 | 6.43 M | $89.57 M | 0.00% | 6.66% |
| VANGUARD GROUP INC | 11/13/2024 | 5.89 M | $82.01 M | 27.34% | 6.09% |
| BRAIDWELL LP | 11/14/2024 | 4.87 M | $67.89 M | 60.54% | 5.04% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.71 M | $65.60 M | 100.00% | 4.87% |
| FRANKLIN RESOURCES INC | 11/27/2024 | 3.87 M | $55.34 M | 2.31% | 4.00% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2024 | 3.10 M | $43.23 M | 100.00% | 3.21% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 2.98 M | $41.55 M | 4.60% | 3.09% |
| STATE STREET CORP | 11/14/2024 | 2.82 M | $39.34 M | -0.11% | 2.92% |
| ESTUARY CAPITAL MANAGEMENT LP | 11/14/2024 | 2.74 M | $38.22 M | 4.12% | 2.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2024 | 2.62 M | $36.46 M | -10.45% | 2.71% |
| VIKING GLOBAL INVESTORS LP | 11/14/2024 | 2.56 M | $35.64 M | 0.00% | 2.65% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 2.54 M | $35.45 M | 8.25% | 2.63% |
| VESTAL POINT CAPITAL, LP | 11/14/2024 | 2.50 M | $34.83 M | 100.00% | 2.59% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.18 M | $30.31 M | 18.37% | 2.25% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 2.11 M | $29.45 M | 74.55% | 2.19% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 11/04/2024 | 1.83 M | $25.46 M | 8.24% | 1.89% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.77 M | $24.72 M | -6.77% | 1.84% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.43 M | $19.96 M | 10.53% | 1.48% |
| BOXER CAPITAL, LLC | 11/14/2024 | 1.19 M | $16.58 M | 0.00% | 1.23% |
| FIRST TURN MANAGEMENT, LLC | 11/07/2024 | 947,878 | $13.20 M | 100.00% | 0.98% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 924,140 | $12.87 M | 1.69% | 0.96% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 900,000 | $12.54 M | 100.00% | 0.93% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 862,068 | $12.01 M | 100.00% | 0.89% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 836,195 | $11.65 M | -5.85% | 0.87% |
| WOODLINE PARTNERS LP | 11/14/2024 | 797,333 | $11.11 M | 12.69% | 0.83% |
| MORGAN STANLEY | 11/14/2024 | 774,511 | $10.79 M | 363.10% | 0.80% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 750,363 | $10.45 M | 12.59% | 0.78% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 721,581 | $10.05 M | 142.11% | 0.75% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 720,108 | $10.03 M | 29.72% | 0.75% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 689,655 | $9.61 M | 100.00% | 0.71% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 526,732 | $7.34 M | -25.44% | 0.55% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 507,448 | $7.07 M | 14.61% | 0.53% |
| STEMPOINT CAPITAL LP | 11/13/2024 | 506,978 | $7.06 M | 100.00% | 0.52% |
| CITADEL ADVISORS LLC | 11/14/2024 | 484,261 | $6.75 M | 31.02% | 0.50% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 407,501 | $5.68 M | 36.19% | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 347,627 | $4.84 M | 0.00% | 0.36% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 342,172 | $4.77 M | -13.73% | 0.35% |
| CANDRIAM S.C.A. | 11/13/2024 | 290,014 | $4.04 M | 0.00% | 0.30% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 11/13/2024 | 205,675 | $2.87 M | 100.00% | 0.21% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 192,194 | $2.68 M | 8.18% | 0.20% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 189,297 | $2.64 M | 8.96% | 0.20% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2024 | 185,000 | $2.58 M | -80.21% | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 10/10/2024 | 184,230 | $2.57 M | 100.00% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 170,738 | $2.38 M | -18.07% | 0.18% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 163,698 | $2.28 M | -14.25% | 0.17% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2024 | 147,319 | $2.05 M | -25.00% | 0.15% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 143,135 | $1.99 M | -36.20% | 0.15% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 136,433 | $1.90 M | -8.84% | 0.14% |
Day One Biopharmaceuticals, Inc.institutional Ownership - FAQ's
During the previous two years, 191 institutional investors and hedge funds held shares of Day One Biopharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 7.87 M
FMR LLC: 7.41 M
Atlas Venture Life Science Advisors, LLC: 6.43 M
VANGUARD GROUP INC: 5.89 M
BRAIDWELL LP: 4.87 M
BlackRock Funding, Inc. /DE: 4.71 M
94.97% of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 95.77 M shares in the last 24 months. This purchase volume represents approximately $1.21 B in transactions.